miR-765 Acts as a Tumor Promoter and Indicates Poor Prognosis in Non-Small Cell Lung Cancer.

Wang J, Wang L, Zhang C

Open source

DOI
10.2147/ott.s284212
Published
2021
Container
OncoTargets and therapy
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/ott.s284212,
  title = {miR-765 Acts as a Tumor Promoter and Indicates Poor Prognosis in Non-Small Cell Lung Cancer.},
  author = {Wang J and Wang L and Zhang C},
  year = {2021},
  journal = {OncoTargets and therapy},
  doi = {10.2147/ott.s284212},
  url = {https://doi.org/10.2147/ott.s284212}
}

RIS

TY  - JOUR
TI  - miR-765 Acts as a Tumor Promoter and Indicates Poor Prognosis in Non-Small Cell Lung Cancer.
AU  - Wang J
AU  - Wang L
AU  - Zhang C
PY  - 2021
JO  - OncoTargets and therapy
DO  - 10.2147/ott.s284212
UR  - https://doi.org/10.2147/ott.s284212
ER  - 

APA

J, W., L, W., & C, Z. (2021). miR-765 Acts as a Tumor Promoter and Indicates Poor Prognosis in Non-Small Cell Lung Cancer.. OncoTargets and therapy. https://doi.org/10.2147/ott.s284212

Source records